For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.
Cellular Peptide
Thymosin Alpha-1
A 28-residue acetylated peptide derived from prothymosin alpha, studied in immune-modulation research for its effects on T-cell maturation and TLR signaling.
Quantity
$39.99
Bundle & save
Delivery
Order by 3:00 PM ET for same-day dispatch
Cutoff 3:00 PM ET · same-day dispatch
Estimated arrival in 2–3 business days
Overnight shipping available
Free shipment protection included
Thymosin Alpha-1
1 × 10mg · $39.99
99% purity, QC passed
HPLC + mass-spec verified
Shipment protection
Free on every order
Free shipping over $150
Same-day dispatch before 3PM ET
Certificate of Analysis
Third-party tested · Independent analytical lab
10mg
99.84%latest
| Tested | Measured | Purity |
|---|---|---|
| Jun 2026 | 12.11mg | 99.84% |
| May 2026 | 12.31mg | 99.90% |
| Apr 2026 | 12.01mg | 99.82% |
| Feb 2026 | 12.13mg | 99.93% |
| Jan 2026 | 12.66mg | 99.45% |
| Jan 2026 | 11.37mg | 99.76% |
| Jan 2026 | 11.37mg | 99.65% |
| Dec 2025 | 12.01mg | 99.75% |
| Nov 2025 | 12.10mg | 99.81% |
Frequently researched together
Commonly studied alongside Thymosin Alpha-1.
Compound information
Technical specifications
Molecular profile
| Type | Synthetic acetylated polypeptide |
| CAS number | 62304-98-7 |
| Molecular weight | 3108.3 g/mol |
| Amino acids | 28 |
| Sequence | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN |
| Formula | C129H215N33O55 |
Storage & stability
- ❄️
Lyophilized (powder)
-20°C · stable 2+ years
- ❄️
Reconstituted
2–8°C · use within 30 days
Sources & references
Peer-reviewed literature, for research context
- World Journal of Virology
Thymosin alpha 1: A comprehensive review of the literature
2020·DOI: 10.5501/wjv.v9.i5.67·PMID: 33362999Dominari A, Hathaway III D, Pandav K, et al.
View source - Hepatology
Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial
1998·PMID: 9581695Chien RN, Liaw YF, Chen TC, et al.
View source - Expert Opinion on Biological Therapy
Immune Modulation with Thymosin Alpha 1 Treatment
2016·PMID: 27450734Tuthill C, Rios I, McBeath R.
View source - Blood
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance
2006·PMID: 16741252Romani L, Bistoni F, Perruccio K, et al.
View source - Clinical Pharmacokinetics
Pharmacokinetics of thymosin alpha1 after subcutaneous injection of three different formulations in healthy volunteers
1999·PMID: 10027483Rost KL, et al.
View source
Important research notice
Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.
Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.
By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.